SUPRENZA

Peak

phentermine hydrochloride

NDAORALTABLET, ORALLY DISINTEGRATING
Approved
Jun 2011
Lifecycle
Peak
Competitive Pressure
8/100

Loss of Exclusivity

LOE Date
Mar 14, 2029
36 months away
Patent Expiry
Mar 14, 2029

Patent Records (1)

Patent #ExpiryTypeUse Code
8440170
Mar 14, 2029
Product
—
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers